Consequently, we identified seven CXC subfamily ligands that were significantly correlated with DFS in CRC patients (p<0.05, Table 1), including CXCL1, CXCL3, CXCL9, CXCL10, CXCL11, CXCL13, and CXCL14. This evidence concerns the gene CXCL13 and colorectal carcinoma.